Free Trial

BTIG Research's Rating of (DEXO) on 12/3/2010

On December 3, 2010, BTIG Research updated its outlook on (DEXO) (NYSE:DEXO) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from BTIG Research

DateCompanyAction
10/10/2025
Aaron's Holdings Company, Inc. stock logo
PRG
Aaron's
Reiterated Rating
10/10/2025
Rocket Companies, Inc. stock logo
RKT
Rocket Companies
Reiterated Rating
10/10/2025
Carvana Co. stock logo
CVNA
Carvana
Reiterated Rating
10/10/2025
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
Initiated Coverage
10/10/2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Lower Price Target
10/9/2025
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
Initiated Coverage
More Ratings From BTIG Research